known_for alt image article_title name occupation
expert , drug development , regulatory innovation and health policy on issues of higher education , public health in 2010 in seattle susan-desmond-hellman-headshot1 . jpeg susan desmond-hellmann
 susan desmond-hellmann ceo
susan desmond-hellmann

susan desmond-hellmann , md , mph , is the chief executive officer of the bill & melinda gates foundation -lrb- bmgf -rrb- .
on december 17 , 2013 the bill & melinda gates foundation announced that it had selected susan desmond-hellmann , m.d. , m.p.h. , as its next chief executive officer .
desmond-hellmann assumed her role on may 1 , 2014 .
she was previously ucsf chancellor , appointed by uc president mark yudof on may 7 , 2009 , and held the post from august 3 , 2009 to march 2014 .
she became the first woman chancellor of the nearly 150-year-old university .
while chancellor , desmond-hellmann , an oncologist and biotechnology leader , held the arthur and toni rembe rock distinguished professorship at ucsf and oversaw all aspects of the university and medical center 's strategy and operations .
before that she was president of product development at genentech -lrb- march 2004 through april 30 , 2009 -rrb- , where she was credited for her role in the development of two of the first gene-targeted therapies for cancer , avastin and herceptin .
desmond-hellmann also served as a member of genentech 's executive committee , beginning in 1996 .
desmond-hellmann is a recognized leader on issues of higher education , public health , drug development , regulatory innovation and health policy .
